Steriline has delivered an ophthalmic filling and capping line to Bausch + Lomb Italia, part of Bausch + Lomb Corporation, as the company expands production capacity for sterile ophthalmic drug products and eye care formulations.

The OFCM84 line will support growing demand for smaller-volume formats ranging from 10–60 ml and is designed to help reduce risks associated with microbial, particulate, and endotoxin contamination. The system also aligns with the latest Annex 1 Good Manufacturing Practice (GMP) guidelines issued by the European Commission in 2022.

Bausch + Lomb’s Italian operations are headquartered in Vimodrone near Milan with manufacturing in Macherio. It produce eye drops, lens care solutions, and other eye health products.

Steriline’s OFCM84 is a compact, servo-driven linear filling system equipped with eight filling heads and ceramic volumetric pumps. The system includes automated cleaning and sterilization (CIP/SIP) and is designed to minimize contamination risks during aseptic processing.

Bausch + Lomb has ordered two additional Steriline filling lines for its U.S. facilities in Tampa, FL, and Greenville, SC.

Steriline’s OFCM84 ophthalmic filling and capping machine installed at Bausch + Lomb Italia. The linear aseptic system features eight filling heads, automated CIP/SIP capability, and a compact design intended to support high-speed production of small-volume eye care products while meeting current Annex 1 cleanroom requirements.